As a partial MOR and complete KOR agonist, butorphanol is widely used in the clinic as an analgesic, while the incidence of vomiting, gastrointestinal nausea and respiratory depression is less than that of pure MOR agonists (remifentanil, fentanyl, and sufentanil). Here, OPRM1 is linked to Respiratory insufficiency due to muscle weakness.